home / stock / ogn / ogn news


OGN News and Press, Organon & Co. From 11/03/22

Stock Information

Company Name: Organon & Co.
Stock Symbol: OGN
Market: NYSE
Website: organon.com

Menu

OGN OGN Quote OGN Short OGN News OGN Articles OGN Message Board
Get OGN Alerts

News, Short Squeeze, Breakout and More Instantly...

OGN - Organon Non-GAAP EPS of $1.32 beats by $0.22, revenue of $1.54B beats by $20M

Organon press release ( NYSE: OGN ): Q3 Non-GAAP EPS of $1.32 beats by $0.22 . Revenue of $1.54B (-3.8% Y/Y) beats by $20M . Full year 2022 financial guidance ranges updated: Revenue range narrowed to $6.1 billion to $6.2 billion and reflects persisting for...

OGN - Organon Reports Results for the Third Quarter Ended September 30, 2022

Third quarter 2022 revenues of $1,537 million Third quarter diluted earnings per share from continuing operations of $0.89 and non-GAAP adjusted diluted earnings per share from continuing operations of $1.32 Both reported and non-GAAP adjusted diluted earnings per share includ...

OGN - Organon: Thoughts Ahead Of Q3 Earnings

Summary Organon is a spinout of Merck's Established Brands, Women's Health and Biosimilars divisions. The company began life saddled with ~$9.4bn of debt versus annual revenue generation of ~$6.5bn. The share price is down nearly 30% over the past 12 months as currency headwin...

OGN - Merck: Great Medicine For The Portfolio

Summary Merck has seen very strong growth so far this year, even if we strip out the pandemic related contribution. Strong growth has resulted in an uptick in the valuation multiple, all while multiples in the market at large are compressing amidst rising rates. I still like t...

OGN - Merck: A Shield From Recession

Summary Merck has proven to be a resilient healthcare business that has provided growth, while the share price hasn't moved all that much. This year that has changed, and Merck shares are rising above peers with positive returns YTD. The Merck dividend is attractive and should...

OGN - Organon To Report Third Quarter Results and Host Conference Call on November 3, 2022

Organon (NYSE: OGN), a global women’s healthcare company will release its third quarter 2022 financial results on November 3, 2022, prior to the company’s webcast and conference call scheduled for 8:30 a.m. EDT. Interested parties may access the live call via webcast o...

OGN - Miller Value Partners Income Strategy Q3 2022 Letter

Summary In the third quarter of 2022, the Miller Income Strategy returned -7.34% (net of fees) versus a -0.68% return for the ICE BofA US High Yield Index. While the Fed is hiking the cost of money, the lower bound of the Federal funds target rate at the time of this writing is 3....

OGN - Dollar Surges, Weighs on Markets

The S&P 500 notched a new closing low for 2022 as interest rates surged and turmoil rocked global currencies. The Dow Jones Industrials kept on their negative trend, losing 327.76 points to 29,262.65. The S&P 500 fell 38.19 points, or 1% to 3,655.04. The NASDAQ Composite...

OGN - Organon Canada reinforces the need to raise awareness and access for contraception methods with nearly half of pregnancies unplanned

Organon Canada reinforces the need to raise awareness and access for contraception methods with nearly half of pregnancies unplanned Canada NewsWire On World Contraception Day, Organon wants to help tackle the global issue of unintended pregnancies by helping ensure wo...

OGN - Healthcare Industry: The Peaks Are Crumbling

Summary A high level of restructuring is occurring with the Healthcare industry’s largest constituents. Most restructuring is taking the form of splits or spin-offs, but not all incidences look beneficial. This article will summarize coming transactions and provide comm...

Previous 10 Next 10